Integrating Chinese medicine in the management of atrial fibrillation: a retrospective EMR-based study
Phase 2
Not yet recruiting
- Conditions
- atrial fibrillation
- Registration Number
- ITMCTR2024000224
- Lead Sponsor
- Guangdong Provincial Hospital of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
(1) patients aged over 18 years
(2) discharged from the general or any of the three other branches of Guangdong Provincial Hospital of Chinese Medicine between January 2013 and December 2022
(3) diagnosed with any type of atrial fibrillation
Exclusion Criteria
Not applicable.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Chinese medicine's effects on atrial fibrillation pathophysiology?
How does integrating Chinese medicine compare to standard-of-care treatments for atrial fibrillation in clinical outcomes?
Which biomarkers are associated with response to Chinese medicine in atrial fibrillation patients?
What adverse events are reported with Chinese medicine integration for atrial fibrillation management?
Are there combination therapies involving Chinese medicine and antiarrhythmic drugs for atrial fibrillation?